187 related articles for article (PubMed ID: 12824901)
1. PPAR gamma ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells.
Nagamine M; Okumura T; Tanno S; Sawamukai M; Motomura W; Takahashi N; Kohgo Y
Cancer Sci; 2003 Apr; 94(4):338-43. PubMed ID: 12824901
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells.
Takeuchi S; Okumura T; Motomura W; Nagamine M; Takahashi N; Kohgo Y
Jpn J Cancer Res; 2002 Jul; 93(7):774-82. PubMed ID: 12149143
[TBL] [Abstract][Full Text] [Related]
3. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
Yoshida K; Tanabe K; Fujii D; Oue N; Yasui W; Toge T
Anticancer Res; 2003; 23(1A):267-73. PubMed ID: 12680223
[TBL] [Abstract][Full Text] [Related]
4. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.
Baek SJ; Wilson LC; Hsi LC; Eling TE
J Biol Chem; 2003 Feb; 278(8):5845-53. PubMed ID: 12475986
[TBL] [Abstract][Full Text] [Related]
6. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.
Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T
Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617
[TBL] [Abstract][Full Text] [Related]
7. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitination of p53 is involved in troglitazone induced apoptosis in cervical cancer cells.
Chen HM; Zhang DG; Wu JX; Pei DS; Zheng JN
Asian Pac J Cancer Prev; 2014; 15(5):2313-8. PubMed ID: 24716976
[TBL] [Abstract][Full Text] [Related]
10. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity.
Takashima T; Fujiwara Y; Higuchi K; Arakawa T; Yano Y; Hasuma T; Otani S
Int J Oncol; 2001 Sep; 19(3):465-71. PubMed ID: 11494023
[TBL] [Abstract][Full Text] [Related]
11. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.
Toyoda M; Takagi H; Horiguchi N; Kakizaki S; Sato K; Takayama H; Mori M
Gut; 2002 Apr; 50(4):563-7. PubMed ID: 11889080
[TBL] [Abstract][Full Text] [Related]
12. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
Fujii D; Yoshida K; Tanabe K; Hihara J; Toge T
Anticancer Res; 2004; 24(3a):1409-16. PubMed ID: 15274302
[TBL] [Abstract][Full Text] [Related]
13. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.
Yoshimura R; Matsuyama M; Hase T; Tsuchida K; Kuratsukuri K; Kawahito Y; Sano H; Segawa Y; Nakatani T
Int J Mol Med; 2003 Dec; 12(6):861-5. PubMed ID: 14612958
[TBL] [Abstract][Full Text] [Related]
14. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
[TBL] [Abstract][Full Text] [Related]
15. Effect of ligand troglitazone on peroxisome proliferator-activated receptor gamma expression and cellular growth in human colon cancer cells.
Ming M; Yu JP; Meng XZ; Zhou YH; Yu HG; Luo HS
World J Gastroenterol; 2006 Dec; 12(45):7263-70. PubMed ID: 17143939
[TBL] [Abstract][Full Text] [Related]
16. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
[TBL] [Abstract][Full Text] [Related]
18. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms.
Pandhare J; Cooper SK; Phang JM
J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758
[TBL] [Abstract][Full Text] [Related]
19. Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists.
Hase T; Yoshimura R; Mitsuhashi M; Segawa Y; Kawahito Y; Wada S; Nakatani T; Sano H
Urology; 2002 Sep; 60(3):542-7. PubMed ID: 12350514
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide.
Yoshida K; Hirose Y; Tanaka T; Yamada Y; Kuno T; Kohno H; Katayama M; Qiao Z; Sakata K; Sugie S; Shibata T; Mori H
Cancer Sci; 2003 Apr; 94(4):365-71. PubMed ID: 12824906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]